APO Research
Talk to an analyst

APO RESEARCH · REPORT

Livestock Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Livestock Vaccines Market Outlook and Growth Opportunities 2026

26 December 2025205 pages

Choose your research edition.

Industry ResearchLivestock Vaccines Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Livestock Vaccines Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Livestock Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Livestock Vaccines Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Livestock Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Livestock Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Livestock Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Livestock Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Livestock Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Livestock Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Livestock Vaccines market include Boehringer Ingelheim, Ceva, Elanco, Harbin Pharmaceutical Group, Hester Biosciences, Hile, Japfa Comfeed Indonesia, JinYu Biotechnology and MEVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Livestock Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Livestock Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Livestock Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Livestock Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Livestock Vaccines Segment by Company

Boehringer Ingelheim

Ceva

Elanco

Harbin Pharmaceutical Group

Hester Biosciences

Hile

Japfa Comfeed Indonesia

JinYu Biotechnology

MEVAC

Nisseiken

Phibro Animal Health Corporation

Pulike

QYH Biotech Co., Ltd

Vaxxinova®

Venky's

Zoetis

Merck

Livestock Vaccines Segment by Type

Foot and Mouth Disease Vaccine

Bird Flu Vaccine

Porcine Blue Ear Vaccine

Swine Fever Vaccine

Pig Ring Vaccine

Livestock Vaccines Segment by Application

Pig

Cattle and Sheep

Others

Livestock Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Livestock Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Livestock Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Livestock Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Livestock Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Livestock Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Livestock Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Livestock Vaccines industry.

Chapter 3: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Livestock Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Livestock Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Livestock Vaccines Industry Trends Table 2. Livestock Vaccines Industry Drivers Table 3. Livestock Vaccines Industry Opportunities and Challenges Table 4. Livestock Vaccines Industry Restraints Table 5. Global Livestock Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Livestock Vaccines Revenue Share by Company (2021-2026) Table 7. Global Livestock Vaccines Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Livestock Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Livestock Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Livestock Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Livestock Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Livestock Vaccines Company, Product Type & Application Table 13. Global Livestock Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Livestock Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Foot and Mouth Disease Vaccine Table 18. Significant Companies of Bird Flu Vaccine Table 19. Significant Companies of Porcine Blue Ear Vaccine Table 20. Significant Companies of Swine Fever Vaccine Table 21. Significant Companies of Pig Ring Vaccine Table 22. Global Livestock Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Livestock Vaccines Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Livestock Vaccines Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Livestock Vaccines Sales Volume Share by Type (2021-2026) Table 26. Global Livestock Vaccines Sales Volume Share by Type (2027-2032) Table 27. Global Livestock Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Livestock Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Livestock Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Livestock Vaccines Sales Value Share by Type (2021-2026) Table 31. Global Livestock Vaccines Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Pig Table 33. Significant Companies of Cattle and Sheep Table 34. Significant Companies of Others Table 35. Global Livestock Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Livestock Vaccines Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Livestock Vaccines Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Livestock Vaccines Sales Volume Share by Application (2021-2026) Table 39. Global Livestock Vaccines Sales Volume Share by Application (2027-2032) Table 40. Global Livestock Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Livestock Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Livestock Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Livestock Vaccines Sales Value Share by Application (2021-2026) Table 44. Global Livestock Vaccines Sales Value Share by Application (2027-2032) Table 45. Global Livestock Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Livestock Vaccines Sales by Region (2021-2026) & (K Units) Table 47. Global Livestock Vaccines Sales Market Share by Region (2021-2026) Table 48. Global Livestock Vaccines Sales by Region (2027-2032) & (K Units) Table 49. Global Livestock Vaccines Sales Market Share by Region (2027-2032) Table 50. Global Livestock Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Livestock Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Livestock Vaccines Sales Value Share by Region (2021-2026) Table 53. Global Livestock Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Livestock Vaccines Sales Value Share by Region (2027-2032) Table 55. Global Livestock Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Livestock Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Livestock Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Livestock Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Livestock Vaccines Sales by Country (2021-2026) & (K Units) Table 60. Global Livestock Vaccines Sales Market Share by Country (2021-2026) Table 61. Global Livestock Vaccines Sales by Country (2027-2032) & (K Units) Table 62. Global Livestock Vaccines Sales Market Share by Country (2027-2032) Table 63. Global Livestock Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Livestock Vaccines Sales Value Market Share by Country (2021-2026) Table 65. Global Livestock Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Livestock Vaccines Sales Value Market Share by Country (2027-2032) Table 67. Boehringer Ingelheim Company Information Table 68. Boehringer Ingelheim Business Overview Table 69. Boehringer Ingelheim Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Boehringer Ingelheim Livestock Vaccines Product Portfolio Table 71. Boehringer Ingelheim Recent Development Table 72. Ceva Company Information Table 73. Ceva Business Overview Table 74. Ceva Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Ceva Livestock Vaccines Product Portfolio Table 76. Ceva Recent Development Table 77. Elanco Company Information Table 78. Elanco Business Overview Table 79. Elanco Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Elanco Livestock Vaccines Product Portfolio Table 81. Elanco Recent Development Table 82. Harbin Pharmaceutical Group Company Information Table 83. Harbin Pharmaceutical Group Business Overview Table 84. Harbin Pharmaceutical Group Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio Table 86. Harbin Pharmaceutical Group Recent Development Table 87. Hester Biosciences Company Information Table 88. Hester Biosciences Business Overview Table 89. Hester Biosciences Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hester Biosciences Livestock Vaccines Product Portfolio Table 91. Hester Biosciences Recent Development Table 92. Hile Company Information Table 93. Hile Business Overview Table 94. Hile Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Hile Livestock Vaccines Product Portfolio Table 96. Hile Recent Development Table 97. Japfa Comfeed Indonesia Company Information Table 98. Japfa Comfeed Indonesia Business Overview Table 99. Japfa Comfeed Indonesia Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio Table 101. Japfa Comfeed Indonesia Recent Development Table 102. JinYu Biotechnology Company Information Table 103. JinYu Biotechnology Business Overview Table 104. JinYu Biotechnology Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. JinYu Biotechnology Livestock Vaccines Product Portfolio Table 106. JinYu Biotechnology Recent Development Table 107. MEVAC Company Information Table 108. MEVAC Business Overview Table 109. MEVAC Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. MEVAC Livestock Vaccines Product Portfolio Table 111. MEVAC Recent Development Table 112. Nisseiken Company Information Table 113. Nisseiken Business Overview Table 114. Nisseiken Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Nisseiken Livestock Vaccines Product Portfolio Table 116. Nisseiken Recent Development Table 117. Phibro Animal Health Corporation Company Information Table 118. Phibro Animal Health Corporation Business Overview Table 119. Phibro Animal Health Corporation Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Phibro Animal Health Corporation Livestock Vaccines Product Portfolio Table 121. Phibro Animal Health Corporation Recent Development Table 122. Pulike Company Information Table 123. Pulike Business Overview Table 124. Pulike Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Pulike Livestock Vaccines Product Portfolio Table 126. Pulike Recent Development Table 127. QYH Biotech Co., Ltd Company Information Table 128. QYH Biotech Co., Ltd Business Overview Table 129. QYH Biotech Co., Ltd Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio Table 131. QYH Biotech Co., Ltd Recent Development Table 132. Vaxxinova® Company Information Table 133. Vaxxinova® Business Overview Table 134. Vaxxinova® Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Vaxxinova® Livestock Vaccines Product Portfolio Table 136. Vaxxinova® Recent Development Table 137. Venky's Company Information Table 138. Venky's Business Overview Table 139. Venky's Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Venky's Livestock Vaccines Product Portfolio Table 141. Venky's Recent Development Table 142. Zoetis Company Information Table 143. Zoetis Business Overview Table 144. Zoetis Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Zoetis Livestock Vaccines Product Portfolio Table 146. Zoetis Recent Development Table 147. Merck Company Information Table 148. Merck Business Overview Table 149. Merck Livestock Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Merck Livestock Vaccines Product Portfolio Table 151. Merck Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Livestock Vaccines Distributors List Table 155. Livestock Vaccines Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Livestock Vaccines Product Image Figure 2. Global Livestock Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Livestock Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Livestock Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Livestock Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Livestock Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Foot and Mouth Disease Vaccine Image Figure 10. Bird Flu Vaccine Image Figure 11. Porcine Blue Ear Vaccine Image Figure 12. Swine Fever Vaccine Image Figure 13. Pig Ring Vaccine Image Figure 14. Global Livestock Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Livestock Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Livestock Vaccines Sales Volume Share by Type (2021-2032) Figure 17. Global Livestock Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Livestock Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Livestock Vaccines Sales Value Share by Type (2021-2032) Figure 20. Pig Image Figure 21. Cattle and Sheep Image Figure 22. Others Image Figure 23. Global Livestock Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Livestock Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Livestock Vaccines Sales Volume Share by Application (2021-2032) Figure 26. Global Livestock Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Livestock Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Livestock Vaccines Sales Value Share by Application (2021-2032) Figure 29. Global Livestock Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Livestock Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Livestock Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Livestock Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Livestock Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. North America Livestock Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Livestock Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Livestock Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Livestock Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Livestock Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Livestock Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. South America Livestock Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Livestock Vaccines Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Livestock Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Livestock Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Livestock Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Livestock Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Livestock Vaccines Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Livestock Vaccines Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Foot and Mouth Disease Vaccine
  • Bird Flu Vaccine
  • Porcine Blue Ear Vaccine
  • Swine Fever Vaccine
  • Pig Ring Vaccine
Applications
  • Pig
  • Cattle and Sheep
  • Others
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Elanco
  • Harbin Pharmaceutical Group
  • Hester Biosciences
  • Hile
  • Japfa Comfeed Indonesia
  • JinYu Biotechnology
  • MEVAC
  • Nisseiken
  • Phibro Animal Health Corporation
  • Pulike
  • QYH Biotech Co., Ltd
  • Vaxxinova®
  • Venky's
  • Zoetis
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Livestock Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Livestock Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Livestock Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Livestock Vaccines Market Dynamics
  1. 2.1 Livestock Vaccines Industry Trends
  2. 2.2 Livestock Vaccines Industry Drivers
  3. 2.3 Livestock Vaccines Industry Opportunities and Challenges
  4. 2.4 Livestock Vaccines Industry Restraints
3 Livestock Vaccines Market by Company
  1. 3.1 Global Livestock Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Livestock Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Livestock Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Livestock Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Livestock Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Livestock Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Livestock Vaccines Company Product Type and Application
  8. 3.8 Global Livestock Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Livestock Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Livestock Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Livestock Vaccines Market by Type
  1. 4.1 Livestock Vaccines Type Introduction
  2. 4.1.1 Foot and Mouth Disease Vaccine
  3. 4.1.2 Bird Flu Vaccine
  4. 4.1.3 Porcine Blue Ear Vaccine
  5. 4.1.4 Swine Fever Vaccine
  6. 4.1.5 Pig Ring Vaccine
  7. 4.2 Global Livestock Vaccines Sales Volume by Type
  8. 4.2.1 Global Livestock Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Livestock Vaccines Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Livestock Vaccines Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Livestock Vaccines Sales Value by Type
  12. 4.3.1 Global Livestock Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Livestock Vaccines Sales Value by Type (2021-2032)
  14. 4.3.3 Global Livestock Vaccines Sales Value Share by Type (2021-2032)
5 Livestock Vaccines Market by Application
  1. 5.1 Livestock Vaccines Application Introduction
  2. 5.1.1 Pig
  3. 5.1.2 Cattle and Sheep
  4. 5.1.3 Others
  5. 5.2 Global Livestock Vaccines Sales Volume by Application
  6. 5.2.1 Global Livestock Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Livestock Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Livestock Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Livestock Vaccines Sales Value by Application
  10. 5.3.1 Global Livestock Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Livestock Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global Livestock Vaccines Sales Value Share by Application (2021-2032)
6 Livestock Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Livestock Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Livestock Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Livestock Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Livestock Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Livestock Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Livestock Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Livestock Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Livestock Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Livestock Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Livestock Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Livestock Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Livestock Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Livestock Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Livestock Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Livestock Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Livestock Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Livestock Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Livestock Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Livestock Vaccines Sales Value Share by Country, 2025 VS 2032
7 Livestock Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Livestock Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Livestock Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Livestock Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Livestock Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Livestock Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Livestock Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Livestock Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Livestock Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Livestock Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Livestock Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Livestock Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Livestock Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Livestock Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Livestock Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Livestock Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Livestock Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Livestock Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Livestock Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Livestock Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Livestock Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Livestock Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Livestock Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Livestock Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Livestock Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Livestock Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Livestock Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Livestock Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Livestock Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Livestock Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Livestock Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Livestock Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Livestock Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Livestock Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Livestock Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Livestock Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Livestock Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Livestock Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Livestock Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Livestock Vaccines Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva
  8. 8.2.1 Ceva Company Information
  9. 8.2.2 Ceva Business Overview
  10. 8.2.3 Ceva Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Livestock Vaccines Product Portfolio
  12. 8.2.5 Ceva Recent Developments
  13. 8.3 Elanco
  14. 8.3.1 Elanco Company Information
  15. 8.3.2 Elanco Business Overview
  16. 8.3.3 Elanco Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Elanco Livestock Vaccines Product Portfolio
  18. 8.3.5 Elanco Recent Developments
  19. 8.4 Harbin Pharmaceutical Group
  20. 8.4.1 Harbin Pharmaceutical Group Company Information
  21. 8.4.2 Harbin Pharmaceutical Group Business Overview
  22. 8.4.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio
  24. 8.4.5 Harbin Pharmaceutical Group Recent Developments
  25. 8.5 Hester Biosciences
  26. 8.5.1 Hester Biosciences Company Information
  27. 8.5.2 Hester Biosciences Business Overview
  28. 8.5.3 Hester Biosciences Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hester Biosciences Livestock Vaccines Product Portfolio
  30. 8.5.5 Hester Biosciences Recent Developments
  31. 8.6 Hile
  32. 8.6.1 Hile Company Information
  33. 8.6.2 Hile Business Overview
  34. 8.6.3 Hile Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hile Livestock Vaccines Product Portfolio
  36. 8.6.5 Hile Recent Developments
  37. 8.7 Japfa Comfeed Indonesia
  38. 8.7.1 Japfa Comfeed Indonesia Company Information
  39. 8.7.2 Japfa Comfeed Indonesia Business Overview
  40. 8.7.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio
  42. 8.7.5 Japfa Comfeed Indonesia Recent Developments
  43. 8.8 JinYu Biotechnology
  44. 8.8.1 JinYu Biotechnology Company Information
  45. 8.8.2 JinYu Biotechnology Business Overview
  46. 8.8.3 JinYu Biotechnology Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 JinYu Biotechnology Livestock Vaccines Product Portfolio
  48. 8.8.5 JinYu Biotechnology Recent Developments
  49. 8.9 MEVAC
  50. 8.9.1 MEVAC Company Information
  51. 8.9.2 MEVAC Business Overview
  52. 8.9.3 MEVAC Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 MEVAC Livestock Vaccines Product Portfolio
  54. 8.9.5 MEVAC Recent Developments
  55. 8.10 Nisseiken
  56. 8.10.1 Nisseiken Company Information
  57. 8.10.2 Nisseiken Business Overview
  58. 8.10.3 Nisseiken Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nisseiken Livestock Vaccines Product Portfolio
  60. 8.10.5 Nisseiken Recent Developments
  61. 8.11 Phibro Animal Health Corporation
  62. 8.11.1 Phibro Animal Health Corporation Company Information
  63. 8.11.2 Phibro Animal Health Corporation Business Overview
  64. 8.11.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Phibro Animal Health Corporation Livestock Vaccines Product Portfolio
  66. 8.11.5 Phibro Animal Health Corporation Recent Developments
  67. 8.12 Pulike
  68. 8.12.1 Pulike Company Information
  69. 8.12.2 Pulike Business Overview
  70. 8.12.3 Pulike Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Pulike Livestock Vaccines Product Portfolio
  72. 8.12.5 Pulike Recent Developments
  73. 8.13 QYH Biotech Co., Ltd
  74. 8.13.1 QYH Biotech Co., Ltd Company Information
  75. 8.13.2 QYH Biotech Co., Ltd Business Overview
  76. 8.13.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio
  78. 8.13.5 QYH Biotech Co., Ltd Recent Developments
  79. 8.14 Vaxxinova®
  80. 8.14.1 Vaxxinova® Company Information
  81. 8.14.2 Vaxxinova® Business Overview
  82. 8.14.3 Vaxxinova® Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Vaxxinova® Livestock Vaccines Product Portfolio
  84. 8.14.5 Vaxxinova® Recent Developments
  85. 8.15 Venky's
  86. 8.15.1 Venky's Company Information
  87. 8.15.2 Venky's Business Overview
  88. 8.15.3 Venky's Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Venky's Livestock Vaccines Product Portfolio
  90. 8.15.5 Venky's Recent Developments
  91. 8.16 Zoetis
  92. 8.16.1 Zoetis Company Information
  93. 8.16.2 Zoetis Business Overview
  94. 8.16.3 Zoetis Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Zoetis Livestock Vaccines Product Portfolio
  96. 8.16.5 Zoetis Recent Developments
  97. 8.17 Merck
  98. 8.17.1 Merck Company Information
  99. 8.17.2 Merck Business Overview
  100. 8.17.3 Merck Livestock Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Merck Livestock Vaccines Product Portfolio
  102. 8.17.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Livestock Vaccines Value Chain Analysis
  2. 9.1.1 Livestock Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Livestock Vaccines Sales Mode & Process
  6. 9.2 Livestock Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Livestock Vaccines Distributors
  9. 9.2.3 Livestock Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst